Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

A Prospective Observational Multicenter Study on Deferiprone & Deferasirox in Clinical Practice of Pediatric Patients with Transfusion-Dependent B-Thalassemia

Mohsen Saleh Elalfy, Amira Adly, Tamer Hassan, Mohamed Maebid, Rasha el Ashry, Khaled Sayeh, S Regab, Amal Elbeshlawy, Mona Hamdy, M Elshanshoury, Omar Elalfy, S Shehata, M EL Hawy, S Abd el Helim, Eman El Askary, N Shahein

Blood (2021) 138 (Supplement 1): 5044.

https://doi.org/10.1182/blood-2021-149462

Published: 2021

Journal Articles

Safety and Efficacy of Early-Start Deferiprone in Infants and Young Children with Beta-Thalassemia (START study)

Mohsen Saleh Elalfy, Amal El-Beshlawy, Amira Adly, Fatma Soliman Elsayed Ebeid, Caroline Fradette, David Lee, Noemi T Temin, Fernando Tricta, Anna Rozova, Mona Hamdy

Blood (2021) 138 (Supplement 1): 3070.

https://doi.org/10.1182/blood-2021-147595

Published: 2021

Journal Articles

A Prospective Randomized Multicenter Trial Using Either Deferiprone or Deferasirox after an Early Start of Deferiprone or Placebo in Young Children Newly Diagnosed with Transfusion-Dependent Beta-Thalassemia

Mohsen Saleh Elalfy, Amira Adly, Fatma Soliman Elsayed Ebeid, Amal El-Beshlawy, Neveen Salama, Mona Hamdy

Blood (2021) 138 (Supplement 1): 3071.

https://doi.org/10.1182/blood-2021-149359

Published: 2021

Journal Articles

A Randomized Prospective Study to Assess the Effect of Vitamin E on Peroxiredoxin- 2 As a Novel Antioxidant Marker in Young Beta-Thalassemia Major Patients on Different Chelation Therapy

Mohamed Abd el mohsen, Maha Saber, Amira Adly, Eman Ismail, Omar Elalfy, MD, Elghamry Islam, Fatma Ibrahim, Mohsen Saleh Elalfy, MD

Blood (2018) 132 (Supplement 1): 1058.

https://doi.org/10.1182/blood-2018-99-115186

Published: 2018

Journal Articles

A Randomized Trial on the Safety and Efficacy of Early Start of Iron Chelation Therapy with Deferiprone in Newly Diagnosed Children with Transfusion Dependent Thalassemia

Mohsen Saleh Elalfy, MD, Vasilios Berdoukas, MB, BS, Fernando Tricta, MD, Amira Adly, Nyeria Hazza, Hanem Awed, Basma Helal, Mohamed Tarif Salam

Blood (2016) 128 (22): 1286.

https://doi.org/10.1182/blood.V128.22.1286.1286

Published: 2016

Journal Articles

Diet Challenge in G6PD Deficient Egyptian Children: A One- Year Prospective Single Center Study with Genotype - Phenotype Correlation

Mohsen Saleh Elalfy, Amira Adly, Lorena Duca, Tarek Kamal

Blood (2015) 126 (23): 4534.

https://doi.org/10.1182/blood.V126.23.4534.4534

Published: 2015

Journal Articles

Role of Vitamin C As an Adjuvant Therapy with Different Iron Chelators in Young β-Thalassemia Major Patients: Safety and Efficacy in Relation to Tissue Iron Overload

Mohsen Saleh Elalfy, Maha Saber, Amira Adly, Eman Ismail, Mohamed Tarif, Fatma Ibrahim, Omar Elalfy

Blood (2014) 124 (21): 4046.

https://doi.org/10.1182/blood.V124.21.4046.4046

Published: 2014

Journal Articles

Comparison Of Two Combination Iron Chelation Regimens, Deferiprone and Deferasirox Versus Deferiprone and Deferoxamine, In Pediatric Patients With β-Thalassemia Major

Mohsen Saleh Elalfy, Yasser Wali, MD, FRCPCH, (UK), S Tony, Ahmed Samir, Amira Adly

Blood (2013) 122 (21): 559.

https://doi.org/10.1182/blood.V122.21.559.559

Published: 2013

Journal Articles

Therapeutic Superiority and Safety of Combined Hydroxyurea with Recombinant Human Erythropoietin Over Hydroxyurea in B-Thalassemia Intermedia Patients

Mohsen Saleh Elalfy, Amira Adly, Yassmine Elhanawy

Blood (2012) 120 (21): 252.

https://doi.org/10.1182/blood.V120.21.252.252

Published: 2012

Journal Articles

Effect of Antioxidant Therapy On Hepatic Fibrosis and Liver Iron Concentrations In Beta-Thalassemia Major Patients

Mohsen Saleh Elalfy, Atef Attia, Abd El Basat Sayed, Fatma Ibrahim, Amer Mohammed, Amira Adly

Blood (2011) 118 (21): 5292.

https://doi.org/10.1182/blood.V118.21.5292.5292

Published: 2011

NARROW

A Prospective Observational Multicenter Study on Deferiprone & Deferasirox in Clinical Practice of Pediatric Patients with Transfusion-Dependent B-Thalassemia

Safety and Efficacy of Early-Start Deferiprone in Infants and Young Children with Beta-Thalassemia (START study)

A Prospective Randomized Multicenter Trial Using Either Deferiprone or Deferasirox after an Early Start of Deferiprone or Placebo in Young Children Newly Diagnosed with Transfusion-Dependent Beta-Thalassemia

A Randomized Prospective Study to Assess the Effect of Vitamin E on Peroxiredoxin- 2 As a Novel Antioxidant Marker in Young Beta-Thalassemia Major Patients on Different Chelation Therapy

A Randomized Trial on the Safety and Efficacy of Early Start of Iron Chelation Therapy with Deferiprone in Newly Diagnosed Children with Transfusion Dependent Thalassemia

Diet Challenge in G6PD Deficient Egyptian Children: A One- Year Prospective Single Center Study with Genotype - Phenotype Correlation

Role of Vitamin C As an Adjuvant Therapy with Different Iron Chelators in Young β-Thalassemia Major Patients: Safety and Efficacy in Relation to Tissue Iron Overload

Comparison Of Two Combination Iron Chelation Regimens, Deferiprone and Deferasirox Versus Deferiprone and Deferoxamine, In Pediatric Patients With β-Thalassemia Major

Therapeutic Superiority and Safety of Combined Hydroxyurea with Recombinant Human Erythropoietin Over Hydroxyurea in B-Thalassemia Intermedia Patients

Effect of Antioxidant Therapy On Hepatic Fibrosis and Liver Iron Concentrations In Beta-Thalassemia Major Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only